These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38126101)

  • 41. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Granulomatous interstitial nephritis secondary to chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Nasr SH; Shanafelt TD; Hanson CA; Fidler ME; Cornell LD; Sethi S; Chaffee KG; Morris J; Leung N
    Ann Diagn Pathol; 2015 Jun; 19(3):130-6. PubMed ID: 25795422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical Efficacy and Safety of Rituximab Combined with Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia].
    Han HJ; Lu YW; Xia RX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):25-9. PubMed ID: 26913388
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.
    Badoux XC; Keating MJ; Wang X; O'Brien SM; Ferrajoli A; Faderl S; Burger J; Koller C; Lerner S; Kantarjian H; Wierda WG
    Blood; 2011 Mar; 117(11):3016-24. PubMed ID: 21245487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term Follow-up of a Case of Lymphomatoid Papulosis with a Benign Course.
    Balić A; Bartolić L; Ilić I; Radoš J
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):264-266. PubMed ID: 30390731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A unique case of concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and lymphomatoid papulosis in the same biopsy.
    Hibler J; Salavaggione AL; Martin A; Gru AA
    J Cutan Pathol; 2015 Apr; 42(4):276-84. PubMed ID: 25382820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Renal infiltrate by a plasmocytoïd chronic B lymphocytic leukaemia and renal failure: a rare occurrence in nephropathology. A case report and review of the literature].
    Aymard B; Beghoura R; Molina TJ
    Nephrol Ther; 2011 Nov; 7(6):479-87. PubMed ID: 21439927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study.
    Burger JA; Keating MJ; Wierda WG; Hartmann E; Hoellenriegel J; Rosin NY; de Weerdt I; Jeyakumar G; Ferrajoli A; Cardenas-Turanzas M; Lerner S; Jorgensen JL; Nogueras-González GM; Zacharian G; Huang X; Kantarjian H; Garg N; Rosenwald A; O'Brien S
    Lancet Oncol; 2014 Sep; 15(10):1090-9. PubMed ID: 25150798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial.
    Howard DR; Munir T; Hockaday A; Rawstron AC; Collett L; Oughton JB; Allsup D; Bloor A; Phillips D; Hillmen P
    Trials; 2016 Sep; 17(1):456. PubMed ID: 27645620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous, Purpuric Painful Nodules Upon Addition of Ibrutinib to RCVP Therapy in a CLL Patient: A Distinctive Reaction Pattern Reflecting Iatrogenic Th2 to Th1 Milieu Reversal.
    Mulvey JJ; Nuovo GJ; Magro CM
    Am J Dermatopathol; 2016 Jul; 38(7):492-8. PubMed ID: 27043332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia.
    Burger JA; Sivina M; Jain N; Kim E; Kadia T; Estrov Z; Nogueras-Gonzalez GM; Huang X; Jorgensen J; Li J; Cheng M; Clow F; Ohanian M; Andreeff M; Mathew T; Thompson P; Kantarjian H; O'Brien S; Wierda WG; Ferrajoli A; Keating MJ
    Blood; 2019 Mar; 133(10):1011-1019. PubMed ID: 30530801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Xanthoma-like Skin Changes in an Elderly Woman with a Normal Lipid Profile.
    Nockowski P; Woźniak Z; Reich A; Maj J
    Acta Dermatovenerol Croat; 2017 Jul; 25(2):167-169. PubMed ID: 28871936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First reported association of chronic lymphocytic leukaemia and interstitial granulomatous dermatitis.
    Riaz IB; Kamal MU; Segal RJ; Anwer F
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27194675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemophagocytosis in a patient with chronic lymphocytic leukemia and histoplasmosis.
    Rao RD; Morice WG; Phyliky RL
    Mayo Clin Proc; 2002 Mar; 77(3):287-90. PubMed ID: 11888034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Chronic lymphatic leukemia].
    Bergmann M; Wendtner CM
    Dtsch Med Wochenschr; 2015 Apr; 140(7):479-82. PubMed ID: 25826029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
    Tsimberidou AM; Kantarjian HM; Cortes J; Thomas DA; Faderl S; Garcia-Manero G; Verstovsek S; Ferrajoli A; Wierda W; Alvarado Y; O'Brien SM; Albitar M; Keating MJ; Giles FJ
    Cancer; 2003 Apr; 97(7):1711-20. PubMed ID: 12655528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of Fludarabine for the Treatment of Indolent Lymphoma with Chylothorax.
    Wild A; Holasová J; Králiková E
    Klin Onkol; 2018; 31(4):301-304. PubMed ID: 30541315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia.
    Wierda W; O'Brien S; Wen S; Faderl S; Garcia-Manero G; Thomas D; Do KA; Cortes J; Koller C; Beran M; Ferrajoli A; Giles F; Lerner S; Albitar M; Kantarjian H; Keating M
    J Clin Oncol; 2005 Jun; 23(18):4070-8. PubMed ID: 15767647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL).
    Wright N; Voshtina E; George G; Singavi A; Field J
    Int J Hematol; 2019 Dec; 110(6):751-755. PubMed ID: 31494832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leptomeningeal Carcinomatosis in Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature.
    Naydenov AV; Taylor LP
    Oncologist; 2019 Sep; 24(9):1237-1245. PubMed ID: 30842245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.